FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: A consecutive prospective study

Scandinavian Journal of Surgery

Volumn 96, Issue 3, 2007, Pages 209-213

  Sørensen, Michael ^a   Mortensen, F V ^a   Hoyer M ^a   Vilstrup, H ^a   Keiding, S ^a   Astrup, L ^a   Rokkjaer M ^a   Hansen, F ^a   Nielsen, D T ^a   Sorensen S M ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Colorectal cancer; Liver imaging; Liver metastasis; Positron emission tomography; Surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; POSITRON EMISSION TOMOGRAPHY;

EID: 35148849158     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690709600305     Document Type: Article

References (22)

1. Hakama M, Hoff G, Kronborg O, Pahlman L: Screening for colorectal cancer. Acta Oncol 2005;44:425-439
2. Fong Y: Surgical therapy of hepatic colorectal metastasis. Cancer 1999;49:231-255
3. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254-1262
4. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M: Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006;94:982-999
5. Vauthey JN, Zorzi D, Pawlik TM: Making unresectable hepatic colorectal metastases resectable - does it work? Semin Oncol 2005;32(6 Suppl 9):S118-122
6. rd German interdisciplinary consensus conference, "Onko PET III" 21 July and 19 September 2000. Eur J Nucl Med 2001;28(11):1707-1723
7. Warburg O: The metabolism of tumours. Richard Smith. New York, 1931, pp. 129-169
8. Arulampalam THA, Francis DL, Visvikis D, Taylor I, Ell PJ: FDG-PET for the pre-operative evaluation of colorectal liver metastases. EJSO 2004;30:286-291
9. Böhm B, Voth M, Geoghegan J, Hellfritzsch, Petrovich A, Scheele J, Gottschild D: Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 2004;130:266-272
10. Boykin KN, Zibari GB, Lilien DL, McMillan RW, Aultman DF, McDonald JC: The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg 1999;65(12):1183-1185
11. Imdahl A, Reinhardt MJ, Nitzsche EU, Mix M, Dingeldey A, Einert A, Baier P, Farthmann EH: Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences. Langenbecks Arch Surg 2000;385:129-134
12. Rosa F, Meimarakis G, Stahl A, Bumm R, Hahn K, Tatsch K, Dresel St: Colorectal cancer patients before resection of hepatic metastases. Impact of 18F-FDG PET on detecting extrahepatic disease. Nuklearmedizin 2004;43:135-140
13. Ruers TJM, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T, Carstens FHM, Oyen WJG: Value of positron emission tomography with [F-18]Fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Onc 2002;20:388-395
14. Strasberg SM, Dehdashti F, Siegel BA, Drebin JA, Linehan D: Survival of Patients Evaluated by FDG-PET Before Hepatic Resection for Metastatic Colorectal Carcinoma: A Prospective Database Study. Ann Surg 2001;3:293-299
15. Vitola J, Delbeke D, Sandler MP, Campbell MG, Powers TA, Wright K, Chapman WC, Pinson W: Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1966;171:21-26
16. Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright jr. JK, Pinson CW: Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 1998;133:510-516
17. Zealley IA, Skehan SJ, Rawlinson J, Coates G, Nahmias C, Somers S: Selection of patients for resection of hepatic metastases: improved detection of extra-hepatic disease with FDG PET. RadioGraphics 2001;21:55-69
18. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K: Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 2004;45:19-27
19. Zubeldia JM, Bednarczyk EM, Baker JG, Nabi HA. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases. Cancer Biother Radiopharm 2005;20:450-456
20. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg S: Five-years survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-450
21. Delbeke D, Martin WH: PET and PET-CT for evaluation of colorectal carcinoma. Sem Nucl Med 2004;34:209-223
22. Wiering B, Krabbe PFM, Jager GJ, Oyen WJG, Ruers TJM: The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. A systematic review and metaanalysis. Cancer 2005;104:2658-2670